跳到主要內容

臺灣博碩士論文加值系統

(3.236.84.188) 您好!臺灣時間:2021/08/02 21:03
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

: 
twitterline
研究生:康貴柏
研究生(外文):Abdoul Karim Guiro
論文名稱:Knowledge, attitudes, beliefs and practices about HAART among people living with HIV/AIDS in a resource-limited setting: the case of an NGO (AMMIE) in Burkina Faso
論文名稱(外文):Knowledge, attitudes, beliefs and practices about HAART among people living with HIV/AIDS in a resource-limited setting: the case of an NGO (AMMIE) in Burkina Faso
指導教授:黃嵩立黃嵩立引用關係
指導教授(外文):Song-Lih Huang
學位類別:碩士
校院名稱:國立陽明大學
系所名稱:公共衛生研究所
學門:醫藥衛生學門
學類:公共衛生學類
論文種類:學術論文
論文出版年:2009
畢業學年度:97
語文別:英文
論文頁數:116
中文關鍵詞:BeliefKnowledgeAttitudeAdherenceBurkina FasoPractices
外文關鍵詞:BeliefknowkedgeAttitudeAdherenceBurkina FasoPractices
相關次數:
  • 被引用被引用:0
  • 點閱點閱:164
  • 評分評分:
  • 下載下載:24
  • 收藏至我的研究室書目清單書目收藏:2
Introduction: HAART has become available in Burkina Faso in recent years, and it is critical to assess factors, which will affect patients’ adherence to treatment, such as perception about illness and disease, potential effect of medical treatment, side effects, and impact on social life. The aim of the study was to investigate knowledge, attitude, beliefs, and practices (KABPs) about HAART of people living with HIV/AIDS in the northern region of Burkina Faso.

Methods: A clinic-based cross sectional survey was conducted in the Northern region of Burkina Faso, using a structured questionnaire. Of the 412 patients evaluated 306 (74%) were on HAART and had been interviewed in AMMIE’s clinic, 106 (26%) were not on HAART and had been interviewed in their compound during home visit.

Results: Participant had good knowledge about the effect of HAART: 80% knew it could prevent Mother to Child Transmission, 78% knew it cannot cure HIV. Only 24% knew that HIV could be prevented after having sex with someone already infected. The positive attitude score (8 questions) ranged between 8 and 17, with a mean score of 9, indicating generally positive attitudes towards HAART, but there was some concerns about HAART: 87% of the respondents knew that HAART can have side effects, 27% were worried about others might find they were on HAART, 52% agreed that HAART was difficult to take, 23% were worried about having to take HAART in the future, 39% were worried about HAART side effects, and 23% reported that the side effects affect their daily activities. The adherence rate (had ever forgotten to take one’s medication 7 days prior to the survey) was quite high according to self-report, reaching 95%. Also 49% out of 268 respondents were regularly using condom and, 65% had regular visit to the clinic, and 65.5% were able to stay in their jobs. Being on HAART, and having a regular visit to the clinic were significant predictors of knowledge about HAART in multivariate logistic analyses. Having a good attitude toward HAART was a significant predictor for having good adherence to HAART. Distance, number of support, and positive attitude toward HAART was significant predictor of having regular visit to the clinic. Finally marital status, socioeconomic status, distance, number of support and positive attitude toward HAART were significant predictors of being able to stay in work.

Conclusion: The study population has generally positive knowledge, attitude, and adherence towards HAART especially for those taking HAART and had regular visit to the clinic. This is encouraging that HAART is well accepted by the people. Nevertheless an appropriate intervention is necessary to reinforce education message that HAART cannot cure HIV/AIDS and that HIV can be prevented after having sex with an infected person. Finally an outreaching program may be necessary to take care of those who did not visit regularly and those who were lost to follow up.
Introduction: HAART has become available in Burkina Faso in recent years, and it is critical to assess factors, which will affect patients’ adherence to treatment, such as perception about illness and disease, potential effect of medical treatment, side effects, and impact on social life. The aim of the study was to investigate knowledge, attitude, beliefs, and practices (KABPs) about HAART of people living with HIV/AIDS in the northern region of Burkina Faso.

Methods: A clinic-based cross sectional survey was conducted in the Northern region of Burkina Faso, using a structured questionnaire. Of the 412 patients evaluated 306 (74%) were on HAART and had been interviewed in AMMIE’s clinic, 106 (26%) were not on HAART and had been interviewed in their compound during home visit.

Results: Participant had good knowledge about the effect of HAART: 80% knew it could prevent Mother to Child Transmission, 78% knew it cannot cure HIV. Only 24% knew that HIV could be prevented after having sex with someone already infected. The positive attitude score (8 questions) ranged between 8 and 17, with a mean score of 9, indicating generally positive attitudes towards HAART, but there was some concerns about HAART: 87% of the respondents knew that HAART can have side effects, 27% were worried about others might find they were on HAART, 52% agreed that HAART was difficult to take, 23% were worried about having to take HAART in the future, 39% were worried about HAART side effects, and 23% reported that the side effects affect their daily activities. The adherence rate (had ever forgotten to take one’s medication 7 days prior to the survey) was quite high according to self-report, reaching 95%. Also 49% out of 268 respondents were regularly using condom and, 65% had regular visit to the clinic, and 65.5% were able to stay in their jobs. Being on HAART, and having a regular visit to the clinic were significant predictors of knowledge about HAART in multivariate logistic analyses. Having a good attitude toward HAART was a significant predictor for having good adherence to HAART. Distance, number of support, and positive attitude toward HAART was significant predictor of having regular visit to the clinic. Finally marital status, socioeconomic status, distance, number of support and positive attitude toward HAART were significant predictors of being able to stay in work.

Conclusion: The study population has generally positive knowledge, attitude, and adherence towards HAART especially for those taking HAART and had regular visit to the clinic. This is encouraging that HAART is well accepted by the people. Nevertheless an appropriate intervention is necessary to reinforce education message that HAART cannot cure HIV/AIDS and that HIV can be prevented after having sex with an infected person. Finally an outreaching program may be necessary to take care of those who did not visit regularly and those who were lost to follow up.
I. INTRODUCTION 12
Problems of HIV/AIDS (in the world and in Burkina Faso) 12
Background: HAART and it’s correlates 19
Empirical findings of KABPs about HAART 34
Lesson from literature search 37
Research questions, specific aim and study objectives 37
Conceptual Framework: 39
II. MATERIALS AND METHODS 42
Study design 42
Participation rate 43
Inclusion criteria 44
Exclusion criteria 44
Study instrument 45
Questionnaire validity 45
Method of data collection 46
Analytical approach 46
Protection of human subjects 46
III. RESULTS 47
Participation rate 47
Descriptive findings 47
HIV and treatment characteristics 47
Personal characteristics of the Respondents 48
Knowledge about HAART 50
Knowledge related to the prevention of Mother to Child HIV Transmission (PMTCT) by HAART 51
Knowledge related to the fact that HIV infection can be prevented by HAART after having sex with someone who have already HIV/AIDS 52
Knowledge about whether HIV can be cured by HAART 52
Attitude about HAART 54
Positive attitude 54
Negative attitude: concern about HAART, concern about HIV transmission to the others 55
ADHERANCE to HAART 56
Condom use 57
Number and kind of support 58
Sources of information 58
Number of support 58
Regularity of visit to the physician among respondent 60
Assessing whether the respondent is still working 61
IV. DISCUSSION 63
Demographics and HIV treatment factors 63
Knowledge about HAART 65
Attitude about HAART and adherence 67
Being too ill to work or working as usual 70
Condom use 70
Study limitations 71
V. CONCLUSION 73
VI. POLICY IMPLICATION 74
VII. LIST OF TABLES 75
VIII. LIST OF FIGURES 90
IX. REFERENCES 99
X. QUESTIONNAIRES 103
Participants on HAART 103
Participants not yet on HAART 103
Abaasa, A. M., Todd, J., Ekoru, K., Kalyango, J. N., Levin, J., Odeke, E., et al. (2008). Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda. BMC Health Serv Res, 8, 241.
Amberbir, A., Woldemichael, K., Getachew, S., Girma, B., & Deribe, K. (2008). Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia. BMC Public Health, 8, 265.
Bell, D. J., Kapitao, Y., Sikwese, R., van Oosterhout, J. J., & Lalloo, D. G. (2007). Adherence to antiretroviral therapy in patients receiving free treatment from a government hospital in Blantyre, Malawi. J Acquir Immune Defic Syndr, 45(5), 560-563.
Bennett, I. M., Chen, J., Soroui, J. S., & White, S. (2009). The contribution of health literacy to disparities in self-rated health status and preventive health behaviors in older adults. Ann Fam Med, 7(3), 204-211.
Binagwaho, A., & Ratnayake, N. (2009). The role of social capital in successful adherence to antiretroviral therapy in Africa. PLoS Med, 6(1), e18.
BurkinaFaso. (2001). Cadre strategique de lutte contre le VIH/SIDA et les IST 2001-2005. Retrieved. from.
BurkinaFaso. (2005a). Programme National de prise en charge médical de Pv/VIH. Retrieved. from.
BurkinaFaso. (2005b). UNGASS Report. Retrieved. from.
BurkinaFaso. (2006a). 2006 Census of General Population and habitation Retrieved. from.
BurkinaFaso. (2006b). Cadre strategic de lutte contre le VIH/SIDA et les IST 2006-2010. Retrieved. from.
BurkinaFaso. (2008). UNGASS Report. Retrieved. from.
Calmy, A., Klement, E., Teck, R., Berman, D., Pecoul, B., & Ferradini, L. (2004). Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up. AIDS, 18(18), 2353-2360.
Carlucci, J. G., Kamanga, A., Sheneberger, R., Shepherd, B. E., Jenkins, C. A., Spurrier, J., et al. (2008). Predictors of adherence to antiretroviral therapy in rural Zambia. J Acquir Immune Defic Syndr, 47(5), 615-622.
Chesney, M. A. (2000). Factors affecting adherence to antiretroviral therapy. Clin Infect Dis, 30 Suppl 2, S171-176.
Crane, J. T., Kawuma, A., Oyugi, J. H., Byakika, J. T., Moss, A., Bourgois, P., et al. (2006). The price of adherence: qualitative findings from HIV positive individuals purchasing fixed-dose combination generic HIV antiretroviral therapy in Kampala, Uganda. AIDS Behav, 10(4), 437-442.
DiFranceisco, W., Kelly, J. A., Sikkema, K. J., Somlai, A. M., Murphy, D. A., & Stevenson, L. Y. (1998). Differences between completers and early dropouts from 2 HIV intervention trials: a health belief approach to understanding prevention program attrition. Am J Public Health, 88(7), 1068-1073.
Faso, C.-I. (2008). Historique www.cnls.bf: Fasonet.
Fumaz, C. R., Munoz-Moreno, J. A., Molto, J., Ferrer, M. J., Lopez-Blazquez, R., Negredo, E., et al. (2008). Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs. AIDS Care, 20(7), 796-805.
Gellaitry, G., Cooper, V., Davis, C., Fisher, M., Date, H. L., & Horne, R. (2005). Patients' perception of information about HAART: impact on treatment decisions. AIDS Care, 17(3), 367-376.
Halkitis, P., Palamar, J., & Mukherjee, P. (2008). Analysis of HIV medication adherence in relation to person and treatment characteristics using hierarchical linear modeling. AIDS Patient Care STDS, 22(4), 323-335.
Hanson, D. L., Adje-Toure, C., Talla-Nzussouo, N., Eby, P., Borget, M. Y., Kouadio, L. Y., et al. (2009). HIV type 1 drug resistance in adults receiving highly active antiretroviral therapy in Abidjan, Cote d'Ivoire. AIDS Res Hum Retroviruses, 25(5), 489-495.
Hawkins, C., & Murphy, R. (2007). Adherence to antiretroviral therapy in resource-limited settings: everything matters. AIDS, 21(8), 1041-1042.
Horne, R., Buick, D., Fisher, M., Leake, H., Cooper, V., & Weinman, J. (2004). Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART. Int J STD AIDS, 15(1), 38-44.
Horne, R., Cooper, V., Gellaitry, G., Date, H. L., & Fisher, M. (2007). Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework. J Acquir Immune Defic Syndr, 45(3), 334-341.
Horne, R., Graupner, L., Frost, S., Weinman, J., Wright, S. M., & Hankins, M. (2004). Medicine in a multi-cultural society: the effect of cultural background on beliefs about medications. Soc Sci Med, 59(6), 1307-1313.
Horne, R., Hankins, M., & Jenkins, R. (2001). The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit and research. Qual Health Care, 10(3), 135-140.
Hosseinipour, M. C., van Oosterhout, J. J., Weigel, R., Phiri, S., Kamwendo, D., Parkin, N., et al. (2009). The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. AIDS, 23(9), 1127-1134.
Iliyasu, Z., Kabir, M., Abubakar, I. S., Babashani, M., & Zubair, Z. A. (2005). Compliance to antiretroviral therapy among AIDS patients in Aminu Kano Teaching Hospital, Kano, Nigeria. Niger J Med, 14(3), 290-294.
Ironson, G., O'Cleirigh, C., Fletcher, M. A., Laurenceau, J. P., Balbin, E., Klimas, N., et al. (2005). Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med, 67(6), 1013-1021.
Jaffar, S., Grant, A. D., Whitworth, J., Smith, P. G., & Whittle, H. (2004). The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review. Bull World Health Organ, 82(6), 462-469.
Jallow, S., Alabi, A., Sarge-Njie, R., Peterson, K., Whittle, H., Corrah, T., et al. (2009). Virological response to Highly Active Antiretroviral Therapy (HAART) in HIV-2 and HIV-1/HIV-2 Dually Infected Patients in The Gambia and the Emergence of Drug Resistant variants. J Clin Microbiol.
Kim, S. H., & Lee, E. (2008). [The influence of functional literacy on perceived health status in Korean older adults]. Taehan Kanho Hakhoe Chi, 38(2), 195-203.
Kouanfack, C., Laurent, C., Peytavin, G., Ciaffi, L., Ngolle, M., Nkene, Y. M., et al. (2008). Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in cameroon. J Acquir Immune Defic Syndr, 48(2), 216-219.
Laniece, I., Ciss, M., Desclaux, A., Diop, K., Mbodj, F., Ndiaye, B., et al. (2003). Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS, 17 Suppl 3, S103-108.
Laurent, C., Ngom Gueye, N. F., Ndour, C. T., Gueye, P. M., Diouf, M., Diakhate, N., et al. (2005). Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults. J Acquir Immune Defic Syndr, 38(1), 14-17.
Lee, L. M., Karon, J. M., Selik, R., Neal, J. J., & Fleming, P. L. (2001). Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984-1997. JAMA, 285(10), 1308-1315.
Meya, D., Spacek, L. A., Tibenderana, H., John, L., Namugga, I., Magero, S., et al. (2009). Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria. J Int AIDS Soc, 12(1), 3.
Mills, E. J., Nachega, J. B., Bangsberg, D. R., Singh, S., Rachlis, B., Wu, P., et al. (2006). Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med, 3(11), e438.
Mills, E. J., Nachega, J. B., Buchan, I., Orbinski, J., Attaran, A., Singh, S., et al. (2006). Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA, 296(6), 679-690.
Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., d'Arminio Monforte, A., et al. (2003). Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet, 362(9377), 22-29.
Mohammed, H., Kieltyka, L., Richardson-Alston, G., Magnus, M., Fawal, H., Vermund, S. H., et al. (2004). Adherence to HAART among HIV-infected persons in rural Louisiana. AIDS Patient Care STDS, 18(5), 289-296.
Muyingo, S. K., Walker, A. S., Reid, A., Munderi, P., Gibb, D. M., Ssali, F., et al. (2008). Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe. J Acquir Immune Defic Syndr, 48(4), 468-475.
Nachega, J. B., Lehman, D. A., Hlatshwayo, D., Mothopeng, R., Chaisson, R. E., & Karstaedt, A. S. (2005). HIV/AIDS and antiretroviral treatment knowledge, attitudes, beliefs, and practices in HIV-infected adults in Soweto, South Africa. J Acquir Immune Defic Syndr, 38(2), 196-201.
Oyugi, J. H., Byakika-Tusiime, J., Ragland, K., Laeyendecker, O., Mugerwa, R., Kityo, C., et al. (2007). Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS, 21(8), 965-971.
Soria, A., Porten, K., Fampou-Toundji, J. C., Galli, L., Mougnutou, R., Buard, V., et al. (2009). Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients. Antivir Ther, 14(3), 339-347.
Spacek, L. A., Shihab, H. M., Kamya, M. R., Mwesigire, D., Ronald, A., Mayanja, H., et al. (2006). Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. Clin Infect Dis, 42(2), 252-259.
Steele, R. G., Anderson, B., Rindel, B., Dreyer, M. L., Perrin, K., Christensen, R., et al. (2001). Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs. AIDS Care, 13(5), 617-629.
Sule, S. S., Ijadunola, K. T., Onayade, A. A., Fatusi, A. O., Soetan, R. O., & Connell, F. A. (2008). Utilization of primary health care facilities: lessons from a rural community in southwest Nigeria. Niger J Med, 17(1), 98-106.
Tuller, D. M., Bangsberg, D. R., Senkungu, J., Ware, N. C., Emenyonu, N., & Weiser, S. D. (2009). Transportation Costs Impede Sustained Adherence and Access to HAART in a Clinic Population in Southwestern Uganda: A Qualitative Study. AIDS Behav.
UNAIDS. (2007). AIDS epidemic update: December 2007. WHO Library Cataloguing-in-Publication Data, UNAIDS/07.27E / JC1322E
.
UNAIDS. (2008). Report on the global HIV/AIDS epidemic 2008. WHO library Cataloguing-in- Publication Data, “UNAIDS/08.25E / JC1510E”.
Vincke, J., & Bolton, R. (2002). Therapy adherence and highly active antiretroviral therapy: comparison of three sources of information. AIDS Patient Care STDS, 16(10), 487-495.
Ware, N. C., Idoko, J., Kaaya, S., Biraro, I. A., Wyatt, M. A., Agbaji, O., et al. (2009). Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med, 6(1), e11.
Weiss, L., French, T., Finkelstein, R., Waters, M., Mukherjee, R., & Agins, B. (2003). HIV-related knowledge and adherence to HAART. AIDS Care, 15(5), 673-679.
WHO. (2006). Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. WHO Library Cataloguing-in-Publication Data, NLM classification: WC 503.2.
WHO, UNAIDS, & UNICEF. (2008). Toward universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report 2008. WHO library Cataloguing-in- Publication Data, NLM classification: WC 503.6.
Wilkin, T. J., McKinnon, J. E., DiRienzo, A. G., Mollan, K., Fletcher, C. V., Margolis, D. M., et al. (2009). Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes. J Infect Dis, 199(6), 866-871.
Wolf, M. S., Davis, T. C., Arozullah, A., Penn, R., Arnold, C., Sugar, M., et al. (2005). Relation between literacy and HIV treatment knowledge among patients on HAART regimens. AIDS Care, 17(7), 863-873.
Wolf, M. S., Davis, T. C., Osborn, C. Y., Skripkauskas, S., Bennett, C. L., & Makoul, G. (2007). Literacy, self-efficacy, and HIV medication adherence. Patient Educ Couns, 65(2), 253-260.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
無相關期刊